Variant report

Variant	esv3438711
Chromosome Location	chr3:51987612-51992410
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:371)
CpG islands
(count:610)
Chromatin interactive
region (count:13)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:371 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr3:51987562-51987733	K562	blood:	n/a	n/a
2	BACH1	chr3:51989641-51990152	H1-hESC	embryonic stem cell:	n/a	n/a
3	BRCA1	chr3:51990580-51990833	H1-hESC	embryonic stem cell:	n/a	n/a
4	CEBPB	chr3:51987543-51987788	K562	blood:	n/a	chr3:51987659-51987670
5	CEBPB	chr3:51987432-51987872	IMR90	lung:	n/a	chr3:51987659-51987670
6	CEBPB	chr3:51987494-51987839	K562	blood:	n/a	chr3:51987659-51987670
7	CEBPB	chr3:51989361-51989521	H1-hESC	embryonic stem cell:	n/a	n/a
8	CEBPB	chr3:51991378-51991616	K562	blood:	n/a	chr3:51991458-51991469
9	CEBPB	chr3:51987587-51987757	K562	blood:	n/a	chr3:51987659-51987670
10	CEBPB	chr3:51987507-51987812	HepG2	liver:	n/a	chr3:51987659-51987670
11	CEBPB	chr3:51987414-51988105	Hela-S3	cervix:	n/a	chr3:51987659-51987670
12	CEBPB	chr3:51987472-51987814	ECC-1	luminal epithelium:	n/a	chr3:51987659-51987670
13	CEBPB	chr3:51991306-51991617	HepG2	liver:	n/a	chr3:51991458-51991469
14	CEBPB	chr3:51987505-51987831	A549	lung:	n/a	chr3:51987659-51987670
15	CEBPB	chr3:51987551-51987900	ECC-1	luminal epithelium:	n/a	chr3:51987659-51987670
16	CEBPB	chr3:51991299-51991631	IMR90	lung:	n/a	chr3:51991458-51991469
17	CEBPB	chr3:51989325-51989488	Hela-S3	cervix:	n/a	n/a
18	CHD2	chr3:51989831-51990204	H1-hESC	embryonic stem cell:	n/a	n/a
19	CREB1	chr3:51989486-51990093	H1-hESC	embryonic stem cell:	n/a	n/a
20	CREB1	chr3:51989457-51990202	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTBP2	chr3:51989299-51991209	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTCF	chr3:51990553-51990731	GM12878	blood:	n/a	n/a
23	CTCF	chr3:51990520-51990670	NHLF	lung:	n/a	n/a
24	CTCF	chr3:51990580-51990730	GM12868	blood:	n/a	n/a
25	CTCF	chr3:51992000-51992150	HepG2	liver:	n/a	n/a
26	CTCF	chr3:51991960-51992110	NHDF-neo	bronchial:	n/a	n/a
27	CTCF	chr3:51990580-51990727	HepG2	liver:	n/a	n/a
28	CTCF	chr3:51990560-51990710	GM12875	blood:	n/a	n/a
29	CTCF	chr3:51990560-51990710	A549	lung:	n/a	n/a
30	CTCF	chr3:51989980-51990130	HVMF	connective:	n/a	n/a
31	CTCF	chr3:51989960-51990110	GM12870	blood:	n/a	n/a
32	CTCF	chr3:51989940-51990090	HFF-Myc	foreskin:	n/a	n/a
33	CTCF	chr3:51989940-51990090	AG09309	skin:	n/a	n/a
34	CTCF	chr3:51989980-51990130	HAc	cerebellar:	n/a	n/a
35	CTCF	chr3:51989960-51990110	HUVEC	blood vessel:	n/a	n/a
36	CTCF	chr3:51989980-51990130	AG04450	lung:	n/a	n/a
37	CTCF	chr3:51990600-51990750	GM12868	blood:	n/a	n/a
38	CTCF	chr3:51990615-51990616	GM10248	blood:	n/a	n/a
39	CTCF	chr3:51991980-51992130	HBMEC	blood vessel:	n/a	n/a
40	CTCF	chr3:51989973-51990354	Lung_OC	lung:	n/a	n/a
41	CTCF	chr3:51989985-51990164	Fibrobl	skin:	n/a	n/a
42	CTCF	chr3:51990587-51990645	GM20000	blood:	n/a	n/a
43	CTCF	chr3:51990580-51990730	SAEC	small airway:	n/a	n/a
44	CTCF	chr3:51990580-51990730	HA-sp	spinal cord:	n/a	n/a
45	CTCF	chr3:51990020-51990170	SAEC	small airway:	n/a	n/a
46	CTCF	chr3:51990560-51990710	HFF-Myc	foreskin:	n/a	n/a
47	CTCF	chr3:51990860-51991010	GM12867	blood:	n/a	n/a
48	CTCF	chr3:51990540-51990690	RPTEC	kidney:	n/a	n/a
49	CTCF	chr3:51990580-51990730	HRE	kidney:	n/a	n/a
50	CTCF	chr3:51990680-51990830	K562	blood:	n/a	n/a

(count:610 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:51990638-51990688	Jurkat	blood:	n/a
2	chr3:51987688-51987738	PrEC	prostate:	n/a
3	chr3:51991783-51991833	NB4	blood:	n/a
4	chr3:51990638-51990688	T-47D	breast:	n/a
5	chr3:51990575-51990625	BJ	skin:	n/a
6	chr3:51991783-51991833	MCF-7	breast:	n/a
7	chr3:51990301-51990351	HEEpiC	esophagus:	n/a
8	chr3:51989692-51989742	Jurkat	blood:	n/a
9	chr3:51987688-51987738	NHBE	bronchial:	n/a
10	chr3:51987688-51987738	PFSK-1	brain:	n/a
11	chr3:51990301-51990351	IMR90	lung:	fetal
12	chr3:51989764-51989814	SAEC	small airway:	n/a
13	chr3:51988425-51988475	AG04450	lung:	fetal
14	chr3:51988425-51988475	HPAEpiC	pulmonary alveolar:	n/a
15	chr3:51989764-51989814	HEEpiC	esophagus:	n/a
16	chr3:51989692-51989742	BJ	skin:	n/a
17	chr3:51990929-51990979	K562	blood:	n/a
18	chr3:51989369-51989419	HAEpiC	amniotic membrane:	n/a
19	chr3:51989369-51989419	GM12878	blood:	n/a
20	chr3:51987688-51987738	SAEC	small airway:	n/a
21	chr3:51991783-51991833	Jurkat	blood:	n/a
22	chr3:51989369-51989419	NT2-D1	testis:	n/a
23	chr3:51988425-51988475	A549	lung:	n/a
24	chr3:51987688-51987738	SK-N-MC	brain:	n/a
25	chr3:51989692-51989742	HepG2	liver:	n/a
26	chr3:51991783-51991833	HRE	kidney:	n/a
27	chr3:51989764-51989814	HPAEpiC	pulmonary alveolar:	n/a
28	chr3:51987688-51987738	HMEC	breast:	n/a
29	chr3:51989369-51989419	HCM	heart:	n/a
30	chr3:51989692-51989742	Hepatocyte	liver:	n/a
31	chr3:51987688-51987738	U87	brain:	n/a
32	chr3:51987688-51987738	BJ	skin:	n/a
33	chr3:51991783-51991833	Caco-2	colon:	n/a
34	chr3:51990638-51990688	RPTEC	kidney:	n/a
35	chr3:51990301-51990351	GM12891	blood:	n/a
36	chr3:51991783-51991833	PFSK-1	brain:	n/a
37	chr3:51990929-51990979	Jurkat	blood:	n/a
38	chr3:51990301-51990351	CMK	blood:	n/a
39	chr3:51989692-51989742	HEEpiC	esophagus:	n/a
40	chr3:51987688-51987738	HPAEpiC	pulmonary alveolar:	n/a
41	chr3:51990575-51990625	ovcar-3	ovarian:	n/a
42	chr3:51989369-51989419	SK-N-MC	brain:	n/a
43	chr3:51990575-51990625	NHBE	bronchial:	n/a
44	chr3:51990575-51990625	CMK	blood:	n/a
45	chr3:51990638-51990688	HCM	heart:	n/a
46	chr3:51989764-51989814	HCPEpiC	choroid plexus:	n/a
47	chr3:51987688-51987738	MCF-7	breast:	n/a
48	chr3:51990575-51990625	HCM	heart:	n/a
49	chr3:51990575-51990625	Hepatocyte	liver:	n/a
50	chr3:51989764-51989814	LNCaP	prostate:	n/a

(count:13 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:51988009..51992311-chr3:51992660..51997455,6	K562	blood:
2	chr3:51982600..51984410-chr3:51985795..51988136,2	K562	blood:
3	chr3:51985563..51987517-chr3:51990241..51992502,2	MCF-7	breast:
4	chr3:51980605..51983550-chr3:51988202..51990542,2	MCF-7	breast:
5	chr3:51988573..51991523-chr3:52028412..52030001,2	K562	blood:
6	chr3:51984016..51985796-chr3:51991262..51993294,2	MCF-7	breast:
7	chr3:51989698..51992601-chr3:51995625..51997375,2	MCF-7	breast:
8	chr3:51976311..51979172-chr3:51989239..51992217,2	K562	blood:
9	chr3:51987928..51991924-chr3:52001407..52003695,4	MCF-7	breast:
10	chr3:51987614..51990073-chr3:52025987..52029912,3	K562	blood:
11	chr3:51985305..51989166-chr3:51989564..51992012,3	K562	blood:
12	chr3:51991130..51993001-chr3:51999490..52001486,2	MCF-7	breast:
13	chr3:51985305..51989166-chr3:51989564..51992012,3	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PCBP4-2	chr3:51985865-51987918	NONHSAT089889

No data

Variant related genes	Relation type
GPR62	TF binding region
GPR62	CpG island
ENSG00000090097	chromatin interactions
ENSG00000162244	chromatin interactions
ENSG00000041880	chromatin interactions

Extended variants
information (count: 181 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:181 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs567655068	chr3:51987655-51987656	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
2	rs538201745	chr3:51987678-51987679	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
3	rs556514272	chr3:51987688-51987689	Enhancers Weak transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
4	rs577978939	chr3:51987705-51987706	Enhancers Weak transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
5	rs186979498	chr3:51987774-51987775	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
6	rs531121952	chr3:51987849-51987850	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
7	rs551209244	chr3:51988000-51988001	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs191232876	chr3:51988012-51988013	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs542709661	chr3:51988057-51988058	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs183484688	chr3:51988106-51988107	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs115295376	chr3:51988135-51988136	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs188466083	chr3:51988156-51988157	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs557686192	chr3:51988162-51988163	Enhancers Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs146575677	chr3:51988217-51988218	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs193219816	chr3:51988220-51988221	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs533481968	chr3:51988233-51988234	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs114215530	chr3:51988234-51988235	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs560787713	chr3:51988262-51988263	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs527835028	chr3:51988276-51988277	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs576765755	chr3:51988319-51988320	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs141316093	chr3:51988323-51988324	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs114325655	chr3:51988337-51988338	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs76624158	chr3:51988367-51988368	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs550232431	chr3:51988393-51988394	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs144755316	chr3:51988418-51988419	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs536888172	chr3:51988419-51988420	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs538980513	chr3:51988425-51988426	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs553736349	chr3:51988426-51988427	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs368792964	chr3:51988434-51988435	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs529881466	chr3:51988455-51988456	Weak transcription Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs565873807	chr3:51988524-51988525	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs536021823	chr3:51988569-51988570	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs554669218	chr3:51988626-51988627	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs567001540	chr3:51988632-51988633	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs372591448	chr3:51988651-51988652	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs115322875	chr3:51988676-51988677	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs576799441	chr3:51988737-51988738	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs574421114	chr3:51988750-51988751	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs76122118	chr3:51988752-51988753	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs111973853	chr3:51988765-51988766	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs543099691	chr3:51988803-51988804	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs558172890	chr3:51988842-51988843	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs375440816	chr3:51988879-51988880	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs545689762	chr3:51988895-51988896	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs560582900	chr3:51988981-51988982	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs527901962	chr3:51989006-51989007	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs80054596	chr3:51989018-51989019	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs561447165	chr3:51989037-51989038	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs531880146	chr3:51989040-51989041	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs138571826	chr3:51989103-51989104	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
Glioblastoma multiforme	21080181	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Melanoma	20688739	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	16397240	CNVD
Breast cancer	22032731	CNVD
Non-small cell lung cancer	20864512	CNVD
Colorectal cancer	16912164	CNVD
Non-small cell lung cancer	19010865	CNVD
Colorectal cancer	16272173	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Breast cancer	21785460	CNVD
Neuroblastoma	17327916	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Bladder cancer	21909424	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Septo-optic dysplasia	21572526	CNVD
Biliary cancer	19435499	CNVD
Squamous cell cancer	20885788	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Myelofibrosis	22110671	CNVD
Urothelial cell carcinoma	18451213	CNVD
Ventriculomegaly	21325761	CNVD
Breast cancer	16608533	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:561 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:51977200-51989200	Weak transcription	Ovary	ovary
2	chr3:51977200-51992000	Weak transcription	Aorta	Aorta
3	chr3:51977400-51989200	Weak transcription	Esophagus	oesophagus
4	chr3:51977600-51989000	Weak transcription	Duodenum Smooth Muscle	Duodenum
5	chr3:51977600-51989000	Weak transcription	Pancreas	Pancrea
6	chr3:51977600-51989400	Weak transcription	Left Ventricle	heart
7	chr3:51977800-51987800	Weak transcription	Rectal Mucosa Donor 29	rectum
8	chr3:51977800-51989400	Weak transcription	Colon Smooth Muscle	Colon
9	chr3:51980400-51989400	Weak transcription	Right Ventricle	heart
10	chr3:51980600-51989200	Weak transcription	Gastric	stomach
11	chr3:51980800-51988000	Weak transcription	Brain Cingulate Gyrus	brain
12	chr3:51982400-51987800	Weak transcription	Brain Inferior Temporal Lobe	brain
13	chr3:51983400-51988400	Weak transcription	Colonic Mucosa	Colon
14	chr3:51983400-51989000	Weak transcription	Brain Anterior Caudate	brain
15	chr3:51983400-51989000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
16	chr3:51983400-51989000	Weak transcription	Stomach Smooth Muscle	stomach
17	chr3:51983400-51989400	Weak transcription	Lung	lung
18	chr3:51983600-51987800	Weak transcription	NHLF	lung
19	chr3:51983600-51989000	Weak transcription	Skeletal Muscle Female	skeletal muscle
20	chr3:51983600-51989200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
21	chr3:51983600-51989200	Weak transcription	Adipose Nuclei	Adipose
22	chr3:51983600-51989200	Weak transcription	Spleen	Spleen
23	chr3:51983800-51990200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
24	chr3:51984000-51989200	Weak transcription	Skeletal Muscle Male	skeletal muscle
25	chr3:51984400-51989200	Weak transcription	Liver	Liver
26	chr3:51986200-51993400	Weak transcription	HepG2	liver
27	chr3:51987000-51987800	Enhancers	Monocytes-CD14+_RO01746	blood
28	chr3:51987000-51988200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
29	chr3:51987000-51988200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
30	chr3:51987000-51988400	Enhancers	Hela-S3	cervix
31	chr3:51987000-51989000	Enhancers	Primary monocytes fromperipheralblood	blood
32	chr3:51987200-51987800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr3:51987200-51987800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr3:51987200-51987800	Enhancers	NHDF-Ad	bronchial
35	chr3:51987200-51988000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr3:51987200-51988000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr3:51987200-51988000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
38	chr3:51987200-51988000	Enhancers	Muscle Satellite Cultured Cells	--
39	chr3:51987200-51988200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr3:51987200-51988200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
41	chr3:51987200-51988200	Enhancers	Osteobl	bone
42	chr3:51987200-51989000	Enhancers	Brain Angular Gyrus	brain
43	chr3:51987200-51989000	Enhancers	Brain Hippocampus Middle	brain
44	chr3:51987400-51987800	Weak transcription	HSMMtube	muscle
45	chr3:51987400-51988000	Enhancers	NH-A	brain
46	chr3:51987400-51988800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
47	chr3:51987600-51987800	Enhancers	Psoas Muscle	Psoas
48	chr3:51987600-51988000	Enhancers	HSMM	muscle
49	chr3:51987600-51989400	Enhancers	Brain Substantia Nigra	brain
50	chr3:51987600-51990200	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links